Menu
Not yet recruiting NCT07503795

Outcomes of Definitive Radiotherapy for Bladder Cancer

— Observational Bladder Cancer (BC)

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Radiotherapy followed by chemotherapy.
Who it may be relevant to
Registry conditions: Bladder Cancer (BC). Basic parameters: No limits · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Egypt
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Outcomes of Definitive Radiotherapy for Bladder Cancer: Real-World Experience From a Single Center

Overview

this is an observational study for patients with non metastatic bladder cancer recieving local radical radiotherapy with curative intent recieving radical dose of radiotherapy with or without chemosensitizer

Interventions

  • Radiation Radiotherapy followed by chemotherapy
    it is observational study for patient recieved defentive radiotherapy

Primary outcome measures

  • overall survival, it is defined as time from initiation of treatment till death due to any cause or last date for follow up [Time frame: one and two year]
  • bladder intact events free survival , which is the time from initiation of radical ttt till occurrence of bladder recurrence [Time frame: one and two year]
  • disease free survival , it is time from starting radical ttt till occurrance of 1st recurrence or distant metastasis [Time frame: one and two years]
Secondary outcome measures (1)
  • adverse events , it is treatment related toxicity and side effects [Time frame: one year]

Eligibility criteria

Inclusion criteria

  • Histologically confirmed urothelial carcinoma or variants; definitive intent radiotherapy

Exclusion criteria

  • Palliative radiotherapy only; prior radical cystectomy; or incomplete follow-up data.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Case-only

Study locations

Egypt · 1 center
  • Sohag University Hospitals — Sohag

Identifiers

NCT: NCT07503795 · Soh-Med-25-12___15PD

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗